INCY
Incyte CorporationHealthcare · $25.0B market cap
Verdict
Share price
$115.30
close of Oct 3, 2026
Fair value
$142.71
Sticker Price
Payback Price
$57.08
buy price
INCY is Undervalued: at $115.30 it trades 19% below its fair value of $142.71. Its buy price (Payback Price) is $57.08, 50% below today's price. Business quality is strong: 4 of 5 key numbers clear the 10% bar.
How we valued it
Free Cash Flow. Sales grew 15% a year over the last 3 years, below the 15% we look for in a fast grower, so we value it on its free cash flow instead of an earnings forecast.
Business quality
4 of 5 clear the 10% bar. What are the Big Five?
Follow INCY
Get notified when it reaches its buy price of $57.08. Free.
Create a free accountSuperinvestors
2 of the investors we track hold INCY. Who we track
Insider activity
Since Jun 30, 2026: no open-market purchases, 20 sales worth $15.4M and 64 other filings (stock awards, tax withholding and similar). Why purchases matter
Sales
CAGNONI PABLO J
President, Global Head of R&D · 2026-08-19
Sold
$1.4M
CAGNONI PABLO J
President, Global Head of R&D · 2026-08-12
Sold
$1.3M
Mayes Patrick A
EVP & Chief Scientific Officer · 2026-08-05
Sold
$274K
CAGNONI PABLO J
President, Global Head of R&D · 2026-08-05
Sold
$1.3M
Mayes Patrick A
EVP & Chief Scientific Officer · 2026-08-03
Sold
$729K
Show all 20 salesShow fewer
Mayes Patrick A
EVP & Chief Scientific Officer · 2026-07-31
Sold
$274K
Mayes Patrick A
EVP & Chief Scientific Officer · 2026-07-31
Sold
$40K
Mayes Patrick A
EVP & Chief Scientific Officer · 2026-07-31
Sold
$10K
Mayes Patrick A
EVP & Chief Scientific Officer · 2026-07-31
Sold
$196K
Mayes Patrick A
EVP & Chief Scientific Officer · 2026-07-31
Sold
$196K
Mayes Patrick A
EVP & Chief Scientific Officer · 2026-07-31
Sold
$342K
Mayes Patrick A
EVP & Chief Scientific Officer · 2026-07-31
Sold
$561K
Mayes Patrick A
EVP & Chief Scientific Officer · 2026-07-31
Sold
$737K
Mayes Patrick A
EVP & Chief Scientific Officer · 2026-07-31
Sold
$261K
Mayes Patrick A
EVP & Chief Scientific Officer · 2026-07-31
Sold
$637K
Mayes Patrick A
EVP & Chief Scientific Officer · 2026-07-31
Sold
$1.8M
CAGNONI PABLO J
President, Global Head of R&D · 2026-07-31
Sold
$1.9M
Issa Mohamed Khairie
EVP, Head of U.S. Commercial · 2026-07-16
Sold
$126K
Stein Steven H
CMO & Head of Late-Stage Dev. · 2026-07-16
Sold
$215K
Stein Steven H
CMO & Head of Late-Stage Dev. · 2026-07-15
Sold
$3.2M
Other filings
Basi Ramitpal K
EVP, Human Resources · 2026-08-25
Tax withholding
$65K
Mayes Patrick A
EVP & Chief Scientific Officer · 2026-08-05
Option exercise
$235K
Mayes Patrick A
EVP & Chief Scientific Officer · 2026-08-03
Option exercise
$638K
Mayes Patrick A
EVP & Chief Scientific Officer · 2026-07-31
Option exercise
$179K
Mayes Patrick A
EVP & Chief Scientific Officer · 2026-07-31
Option exercise
$147K
Show all 64 other filingsShow fewer
Mayes Patrick A
EVP & Chief Scientific Officer · 2026-07-31
Option exercise
$167K
Mayes Patrick A
EVP & Chief Scientific Officer · 2026-07-31
Option exercise
$216K
Mayes Patrick A
EVP & Chief Scientific Officer · 2026-07-31
Option exercise
$149K
Mayes Patrick A
EVP & Chief Scientific Officer · 2026-07-31
Option exercise
$684K
Mayes Patrick A
EVP & Chief Scientific Officer · 2026-07-31
Option exercise
$196K
Mayes Patrick A
EVP & Chief Scientific Officer · 2026-07-31
Option exercise
$222K
Mayes Patrick A
EVP & Chief Scientific Officer · 2026-07-31
Option exercise
$132K
Mayes Patrick A
EVP & Chief Scientific Officer · 2026-07-31
Option exercise
$252K
Mayes Patrick A
EVP & Chief Scientific Officer · 2026-07-31
Option exercise
$219K
Mayes Patrick A
EVP & Chief Scientific Officer · 2026-07-31
Option exercise
$140K
Mayes Patrick A
EVP & Chief Scientific Officer · 2026-07-31
Option exercise
$208K
Mayes Patrick A
EVP & Chief Scientific Officer · 2026-07-31
Option exercise
$9K
Mayes Patrick A
EVP & Chief Scientific Officer · 2026-07-31
Option exercise
$34K
Heeson Lee
EVP, Head of Incyte Intl · 2026-07-23
Award
13,498 shares
Heeson Lee
EVP, Head of Incyte Intl · 2026-07-23
Award
$1.8M
Morrissey Michael James
EVP, Head of Tech. Operations · 2026-07-23
Award
$750K
Morrissey Michael James
EVP, Head of Tech. Operations · 2026-07-23
Award
8,999 shares
Meury William
Chief Executive Officer · 2026-07-16
Award
$9.0M
Meury William
Chief Executive Officer · 2026-07-16
Award
80,421 shares
Meury William
Chief Executive Officer · 2026-07-16
Award
26,807 shares
Hoffman Richard A.
EVP & General Counsel · 2026-07-16
Award
7,395 shares
Hoffman Richard A.
EVP & General Counsel · 2026-07-16
Award
18,487 shares
Hoffman Richard A.
EVP & General Counsel · 2026-07-16
Award
$3.7M
Gardner David H
EVP, Chief Strategy Officer · 2026-07-16
Award
7,395 shares
Gardner David H
EVP, Chief Strategy Officer · 2026-07-16
Award
18,487 shares
Gardner David H
EVP, Chief Strategy Officer · 2026-07-16
Award
$3.7M
Basi Ramitpal K
EVP, Human Resources · 2026-07-16
Award
4,991 shares
Basi Ramitpal K
EVP, Human Resources · 2026-07-16
Award
12,479 shares
Basi Ramitpal K
EVP, Human Resources · 2026-07-16
Award
$2.5M
Issa Mohamed Khairie
EVP, Head of U.S. Commercial · 2026-07-16
Award
19,643 shares
Issa Mohamed Khairie
EVP, Head of U.S. Commercial · 2026-07-16
Award
$4.0M
Issa Mohamed Khairie
EVP, Head of U.S. Commercial · 2026-07-16
Award
7,857 shares
CAGNONI PABLO J
President, Global Head of R&D · 2026-07-16
Award
33,508 shares
CAGNONI PABLO J
President, Global Head of R&D · 2026-07-16
Award
$6.7M
CAGNONI PABLO J
President, Global Head of R&D · 2026-07-16
Award
13,403 shares
Mayes Patrick A
EVP & Chief Scientific Officer · 2026-07-16
Award
14,790 shares
Mayes Patrick A
EVP & Chief Scientific Officer · 2026-07-16
Award
$3.0M
Mayes Patrick A
EVP & Chief Scientific Officer · 2026-07-16
Award
5,916 shares
Stein Steven H
CMO & Head of Late-Stage Dev. · 2026-07-16
Award
24,496 shares
Stein Steven H
CMO & Head of Late-Stage Dev. · 2026-07-16
Award
9,798 shares
Stein Steven H
CMO & Head of Late-Stage Dev. · 2026-07-16
Award
$4.9M
Tray Thomas
Principal Accounting Officer · 2026-07-16
Award
$476K
Tray Thomas
Principal Accounting Officer · 2026-07-16
Award
2,834 shares
Issa Mohamed Khairie
EVP, Head of U.S. Commercial · 2026-07-15
Tax withholding
$126K
Stein Steven H
CMO & Head of Late-Stage Dev. · 2026-07-15
Tax withholding
$355K
Tray Thomas
Principal Accounting Officer · 2026-07-15
Tax withholding
$126K
Mayes Patrick A
EVP & Chief Scientific Officer · 2026-07-15
Tax withholding
$174K
CAGNONI PABLO J
President, Global Head of R&D · 2026-07-15
Tax withholding
$570K
Stein Steven H
CMO & Head of Late-Stage Dev. · 2026-07-14
Tax withholding
$2.5M
Tray Thomas
Principal Accounting Officer · 2026-07-14
Tax withholding
$79K
Mayes Patrick A
EVP & Chief Scientific Officer · 2026-07-14
Tax withholding
$50K
CAGNONI PABLO J
President, Global Head of R&D · 2026-07-14
Tax withholding
$2.1M
Stein Steven H
CMO & Head of Late-Stage Dev. · 2026-07-02
Tax withholding
$254K
Meury William
director · 2026-07-02
Tax withholding
$558K
Tray Thomas
Principal Accounting Officer · 2026-07-02
Tax withholding
$56K
Mayes Patrick A
EVP & Chief Scientific Officer · 2026-07-02
Tax withholding
$41K
HARRIGAN EDMUND
director · 2026-06-30
Award
$29K
Clancy Paul J
director · 2026-06-30
Award
$29K
BAKER BROS. ADVISORS LP
director · 2026-06-30
Award
400 shares
About Incyte Corporation
Incyte Corporation is a biopharmaceutical firm engaged in the research, development, and global marketing of its own innovative therapies. Its current product offerings include JAKAFI, prescribed for myelofibrosis and polycythemia vera; PEMAZYRE, a fibroblast growth factor receptor kinase inhibitor that targets oncogenic drivers in various liquid and solid tumor types; and ICLUSIG, a kinase inhibitor utilized for…
Biotechnology
Fair value and Payback Price are estimates from the company's reported financials, not investment advice. Prices as of the close of Oct 3, 2026. How the Payback Price works